NCT06880770 - Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis | Biotech Hunter

Enrollment

140

Participants

Timeline

Start Date

April 24, 2025

Primary Completion Date

March 31, 2029

Study Completion Date

June 30, 2029

Conditions

Severe Hypertriglyceridemia

Interventions

DRUG

Plozasiran

ARO-APOC3 injection

DRUG

Placebo

sterile normal saline (0.9% NaCl)

Trial Locations (7)

RECRUITING

Clinical Research Site 7, Philadelphia

RECRUITING

Clinical Research Site 3, Greensboro

RECRUITING

Clinical Research Site 6, Springfield

RECRUITING

Clinical Research Site 5, North Platte

RECRUITING

Clinical Research Site 1, Mesquite

RECRUITING

Clinical Research Site 2, San Antonio

RECRUITING

Clinical Research Site 4, Santa Clarita